07
Mar
2024
14:00
GMT
09:00
EST
Webinar
Journal Club: SGLT2 Inhibitor Use and Risk of Clinical Events in Patients with Cancer Therapy-Related Cardiac Dysfunction
-
Views:
1654
-
Likes:
9
Overview
Join Dr Walter Schiffer (Washington University in St. Louis, US), Dr Jose Alvarez-Cardona (New York University School of Medicine, US), Prof Dan Lenihan (Saint Francis Healthcare System, US) and Prof Joe Carver (University of Pennsylvania, US) in this month's Journal Club where they’ll be discussing the recently published paper ‘SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction’.
They’ll explore the impact of SGLT2 inhibitors on patients experiencing cardiac dysfunction due to cancer therapy, whether the use of SGLT2 inhibitors affects the occurrence of clinical events in this population and potential therapeutic interventions to mitigate cardiac dysfunction in cancer patients undergoing treatment.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Support Statement
This is an independent activity run by the International Cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by AstraZeneca, BMS/Pfizer Alliance and Sumitomo Pharma through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
Faculty:
Walter Schiffer
Jose Alvarez-Cardona
Daniel Lenihan
Joe Carver
This broadcast is supported by
Faculty Biographies
Walter Schiffer
Dr Walter Schiffer is a Cardiology Fellow at Washington University in St. Louis, Missouri, US.
Dr Schiffer is passionate about cardio-oncology and interested in clinical outcomes research to help improve the cardiovascular health and wellbeing of patients with cancer.
Jose Alvarez-Cardona
Dr Jose Alvarez-Cardona is a Cardiologist and Assistant Professor at New York University School of Medicine, New York, US.
He received his medical degree from University of Puerto Rico School of Medicine. He specialises in cardiomyopathy and heart failure. His specialities include cardiac amyloidosis, cardiomyopathy and heart failure, congestive heart failure, heart transplant and left ventricular assist devices.
Daniel Lenihan
Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Joe Carver
Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.